David Michael Waterhouse (David M Waterhouse, David Waterhouse)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Drug Administration

Small Cell Lung Cancer

Tyrosine Kinase

Top Venues

JCO oncology practice

Future oncology (London, England)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Shubham Agrawal, Rushad Patell, Laura E Dodge, Jennifer W Pegher, Robert L Coleman, David Michael Waterhouse, Daniel Aaron Roberts, Deepa Rangachari
Defining the Educational Needs for a Community-Based Hematology/Oncology Career: A National Needs Assessment. JCO oncology practice (2024)
Shubham Agrawal, Rushad Patell, Laura E Dodge, Jennifer W Pegher, Robert L Coleman, David Michael Waterhouse, Daniel Aaron Roberts, Deepa Rangachari
Defining the Educational Needs for a Community-Based Hematology/Oncology Career: A National Needs Assessment. JCO oncology practice 20 (6) (2024)
David Michael Waterhouse, Patrick J Ward, David R Drosick, Caleb Burdette, Daniel Davies, Molly A Mendenhall
Sustainable Integration of US Food and Drug Administration-Approved Biosimilars: Pharmacy- Versus Physician-Driven Change. JCO oncology practice (2023)
David Michael Waterhouse, Patrick Ward, Suzzette Arnal, Marcus Neubauer, David R Drosick, Dan Davies, Molly A Mendenhall
Closing the Testing Gap: Standardization of Comprehensive Biomarker Testing for Metastatic Non-Small-Cell Lung Cancer in a Large Community Oncology Practice. JCO oncology practice (2023)
Molly A Mendenhall, Andrew Guinigundo, Dan Davies, Patrick J Ward, David R Drosick, David Michael Waterhouse
Integration of Genetic Testing and Counseling in Patients With Breast Cancer in a Large, Multisite Community-Based Practice. JCO oncology practice (2023)
Rachel B Jimenez, Caroline Schenkel, Laura A Levit, Bonnie Hu, Xiudong Jennifer Lei, Robert Donald Harvey, Vicki A Morrison, Teri Pollastro, David Michael Waterhouse, Colin Weekes, Grant R Williams, Suanna Steeby Bruinooge, Elizabeth Garrett-Mayer, Jeffrey M Peppercorn
Oncologists' Perspectives on Individualizing Dose Selection for Patients With Metastatic Cancer. JCO oncology practice 18 (11) (2022)
Hossein Borghaei, Scott N Gettinger, Everett E Vokes, Laura Q M Chow, Marco Angelo Burgio, Javier De Castro Carpeño, Adam Pluzanski, Arrieta Oscar, Osvaldo Arén Frontera, Rita Chiari, Charles Butts, Joanna Wójcik-Tomaszewska, Bruno Coudert, Marina Chiara Garassino, Neal Ready, Enriqueta Felip Font, Miriam Alonso García, David Michael Waterhouse, Manuel Dómine, Fabrice Barlesi, Scott Antonia, Markus Wohlleber, David E Gerber, Grzegorz Czyzewicz, David R Spigel, Lucio Crino, Wilfried Enst Erich Eberhardt, Ang Li, Sathiya Marimuthu, Julie Brahmer
Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (7) (2021)
David Michael Waterhouse, Esmond D Nwokeji, Marley Boyd, John R Penrod, Janet L Espirito, Nicholas J Robert, Melinda J Daumont
Treatment patterns and outcomes of patients with advanced malignant pleural mesothelioma in a community practice setting. Future oncology (London, England) 17 (19) (2021)
Kathryn F Mileham, Suanna Steeby Bruinooge, Charu Aggarwal, Alicia L Patrick, Christiana Davis, Daniel J Mesenhowski, Alexander I Spira, Eric J Clayton, David Michael Waterhouse, Susan Moore, Abdul Rahman Jazieh, Ronald C Chen, Melinda Kaltenbaugh, Jen Hanley Williams, Julie R Gralow, Richard L Schilsky, Elizabeth Garrett-Mayer
Changes Over Time in COVID-19 Severity and Mortality in Patients Undergoing Cancer Treatment in the United States: Initial Report From the ASCO Registry. JCO oncology practice (2021)